Sesen Bio, Inc.(SESN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SESN Sesen Bio, Inc.

休市中 03-07 16:00:00 EST

0.6288

+0.0000

0.00%

最高0.6288	最低0.6288	成交量0.00
今开0.6288	昨收0.6288	日振幅0.00%
总市值639.78万	流通市值588.80万	总股本1,017万
成交额110.07万	换手率0.00%	流通股本936.39万
市净率0.04	ROE-12.05%	每股收益-1.98
52周最高19.30	52周最低0.6288	市盈率-0.32
股息0.00	股息收益率0.00	ROA-11.16%

北京优虎网络科技有限公司

{"stockData":{"symbol":"SESN","market":"US","secType":"STK","nameCN":"Sesen Bio, Inc.","latestPrice":0.6288,"timestamp":1678222800000,"preClose":0.6288,"halted":8,"volume":0,"delay":0,"floatShares":9363869,"shares":10174610,"eps":-1.98298,"marketStatus":"休市中","change":0,"latestTime":"03-07 16:00:00 EST","open":0.6288,"high":0.6288,"low":0.6288,"amount":1100656.108116,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.98298,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"symbolChange":{"newSymbol":"CARM","executeDate":"2023-03-08"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.6288,"volumeRatio":0},"requestUrl":"/m/hq/s/SESN","defaultTab":"news","newsList":[{"id":"2317617628","title":"Sesen Bio Inc股价重挫12.42% 市值跌1365.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2317617628","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2317617628?lang=zh_cn&edition=full","pubTime":"2023-03-06 22:31","pubTimestamp":1678113104,"startTime":"0","endTime":"0","summary":"北京时间2023年03月06日22时31分，Sesen Bio Inc股票出现异动，股价大幅下挫12.42%。Sesen Bio Inc股票所在的生物技术行业中，整体跌幅为0.21%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。消息层面，截至22时31分，Sesen Bio Inc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303062231448266cc3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303062231448266cc3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","SESN"],"gpt_icon":0},{"id":"2316595072","title":"Sesen Bio Inc盘中异动 大幅拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2316595072","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2316595072?lang=zh_cn&edition=full","pubTime":"2023-03-03 00:33","pubTimestamp":1677774825,"startTime":"0","endTime":"0","summary":"北京时间2023年03月03日00时33分，Sesen Bio Inc股票出现波动，股价急速拉升5.60%。Sesen Bio Inc股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Entera Bio Ltd C/Wts 02/07/2023 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Apexigen Inc C/Wts 29/07/2027 涨幅较大，Oncosec Medical Incorporated、Biorestorative Therapies Inc、Cardio Diagnostics Holdings Inc较为活跃，换手率分别为994.64%、734.33%、211.11%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Ocean Biomedical Inc C/Wts 14/02/2028 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为77.02%、61.68%、44.67%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030300334580618d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030300334580618d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SESN","CARM","BK4139"],"gpt_icon":0},{"id":"2311961908","title":"Sesen Bio Inc盘中异动 早盘急速下跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2311961908","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2311961908?lang=zh_cn&edition=full","pubTime":"2023-02-14 00:41","pubTimestamp":1676306500,"startTime":"0","endTime":"0","summary":"北京时间2023年02月13日23时22分，Sesen Bio Inc股票出现异动，股价快速下挫5.57%。截至发稿，该股报0.526美元/股，成交量10.8954万股，换手率0.05%，振幅2.57%。Sesen Bio Inc股票所在的生物技术行业中，整体涨幅为0.81%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。该公司计划对Vicineum进行一项额外的3期临床试验，用于治疗先前用足量或少于足量BCG治疗的患者的膀胱非肌肉侵袭性CIS，并有可能再次提交给BLA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214004145825bf4db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214004145825bf4db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SESN"],"gpt_icon":0},{"id":"2310262528","title":"Sesen Bio Inc盘中异动 大幅跳水5.07%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2310262528","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2310262528?lang=zh_cn&edition=full","pubTime":"2023-02-10 22:30","pubTimestamp":1676039445,"startTime":"0","endTime":"0","summary":"北京时间2023年02月10日22时30分，Sesen Bio Inc股票出现波动，股价快速跳水5.07%。截至发稿，该股报0.550美元/股，成交量6431股，换手率0.00%，振幅0.00%。Sesen Bio Inc股票所在的生物技术行业中，整体跌幅为0.37%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。该公司计划对Vicineum进行一项额外的3期临床试验，用于治疗先前用足量或少于足量BCG治疗的患者的膀胱非肌肉侵袭性CIS，并有可能再次提交给BLA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230210223045846d7412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230210223045846d7412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SESN","BK4139"],"gpt_icon":0},{"id":"2300521274","title":"Sesen Bio Inc盘中异动 早盘股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2300521274","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2300521274?lang=zh_cn&edition=full","pubTime":"2023-01-03 22:32","pubTimestamp":1672756325,"startTime":"0","endTime":"0","summary":"北京时间2023年01月03日22时32分，Sesen Bio Inc股票出现异动，股价快速跳水5.78%。Sesen Bio Inc股票所在的生物技术行业中，整体涨幅为0.48%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。该公司计划对Vicineum进行一项额外的3期临床试验，用于治疗先前用足量或少于足量BCG治疗的患者的膀胱非肌肉侵袭性CIS，并有可能再次提交给BLA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230103223205824a49b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230103223205824a49b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SESN"],"gpt_icon":0},{"id":"2295694483","title":"在Carisma合并中提高特别股息后 Sesen Bio(SESN.US)盘后一度上涨35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2295694483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2295694483?lang=zh_cn&edition=full","pubTime":"2022-12-30 07:18","pubTimestamp":1672355925,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美股周四盘后，Sesen Bio 股价一度上涨35.4%，此前该公司与Carisma Therapeutics Inc.达成了修订后的合并协议，将支付给Sesen股东的一次性特别现金股息提高到7,000万美元，合0.34美元/股，较之前的2500万美元或每股12美分的特别现金分红有所增加。一旦合并完成，Sesen 股东预计将拥有合并后公司25.2%的股份。该集团表示不会支持Carisma交易，并要求每股0.50美元的特别现金股息，即约1亿美元。Sesen 和Carisma与集团达成了一项决议，提出将股息提高到7000万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/854734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","SESN"],"gpt_icon":0},{"id":"2277888415","title":"Sesen Bio Inc股价重挫10.23% 市值跌378.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2277888415","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2277888415?lang=zh_cn&edition=full","pubTime":"2022-10-20 02:51","pubTimestamp":1666205499,"startTime":"0","endTime":"0","summary":"北京时间2022年10月20日02时51分，Sesen Bio Inc股票出现异动，股价急速下挫10.23%。截至发稿，该股报0.450美元/股，成交量74.2709万股，换手率0.37%，振幅5.98%。Sesen Bio Inc股票所在的生物技术行业中，整体跌幅为3.10%。Sesen Bio Inc公司简介：Sesen Bio Inc是一家推进靶向融合蛋白疗法治疗晚期癌症患者的临床公司。该公司计划对Vicineum进行一项额外的3期临床试验，用于治疗先前用足量或少于足量BCG治疗的患者的膀胱非肌肉侵袭性CIS，并有可能再次提交给BLA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221020025139829ad919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221020025139829ad919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SESN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":-0.95},{"period":"1month","weight":-0.95},{"period":"3month","weight":-0.95},{"period":"6month","weight":-0.95},{"period":"1year","weight":-0.95},{"period":"ytd","weight":-0.95}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sesen Bio, Inc.是临床阶段生物制药公司，拥有一个专有的蛋白质工程平台，称为 AMP-Rx，它用于发现和发展蛋白质疗法来治疗眼疾。其治疗方法基于在有疾病的眼睛中的细胞因子，以及它对细胞因子的结构认知和理性设计操控蛋白质调节细胞因子影响的能力。细胞因子是细胞信号分子，在可以产生重要的炎症部分上发现。该公司认为细胞因子在许多眼部疾病的基本病理机制中发挥重要作用，蛋白质疗法是调节眼睛的疾病中细胞因子的影响的有效手段。该公司已利用其 AMP Rx 平台理性设计、操控和生成创新性蛋白治疗候选药物渠道把细胞因子作为靶子，并认为这是控制眼疾的关键。该公司现正进行针对前面的眼睛疾病，包括干眼症疾病和过敏性结膜炎等疾病和后面的眼睛，糖尿病黄斑水肿或二甲醚和葡萄膜炎等疾病的研究和发展方案。 Eleven生物药物公司2008年2月25日在特拉华州法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.099712},{"month":2,"riseRate":0.222222,"avgChangeRate":0.01867},{"month":3,"riseRate":0.6,"avgChangeRate":-0.005559},{"month":4,"riseRate":0.555556,"avgChangeRate":0.369219},{"month":5,"riseRate":0.555556,"avgChangeRate":0.114448},{"month":6,"riseRate":0.666667,"avgChangeRate":0.094226},{"month":7,"riseRate":0.222222,"avgChangeRate":0.118385},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.051285},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.047773},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.045277},{"month":11,"riseRate":0.555556,"avgChangeRate":0.049188},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.029264}],"exchange":"NASDAQ","name":"Sesen Bio, Inc.","nameEN":"Sesen Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sesen Bio, Inc.(SESN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sesen Bio, Inc.(SESN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sesen Bio, Inc.,SESN,Sesen Bio, Inc.股票,Sesen Bio, Inc.股票老虎,Sesen Bio, Inc.股票老虎国际,Sesen Bio, Inc.行情,Sesen Bio, Inc.股票行情,Sesen Bio, Inc.股价,Sesen Bio, Inc.股市,Sesen Bio, Inc.股票价格,Sesen Bio, Inc.股票交易,Sesen Bio, Inc.股票购买,Sesen Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sesen Bio, Inc.(SESN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sesen Bio, Inc.(SESN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}